BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33644822)

  • 1. Molecular characterization of DICER1-mutated pituitary blastoma.
    Nadaf J; de Kock L; Chong AS; Korbonits M; Thorner P; Benlimame N; Fu L; Peet A; Warner J; Ploner O; Shuangshoti S; Albrecht S; Hamel N; Priest JR; Rivera B; Ragoussis J; Foulkes WD
    Acta Neuropathol; 2021 Jun; 141(6):929-944. PubMed ID: 33644822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations.
    de Kock L; Sabbaghian N; Plourde F; Srivastava A; Weber E; Bouron-Dal Soglio D; Hamel N; Choi JH; Park SH; Deal CL; Kelsey MM; Dishop MK; Esbenshade A; Kuttesch JF; Jacques TS; Perry A; Leichter H; Maeder P; Brundler MA; Warner J; Neal J; Zacharin M; Korbonits M; Cole T; Traunecker H; McLean TW; Rotondo F; Lepage P; Albrecht S; Horvath E; Kovacs K; Priest JR; Foulkes WD
    Acta Neuropathol; 2014 Jul; 128(1):111-22. PubMed ID: 24839956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.
    Anglesio MS; Wang Y; Yang W; Senz J; Wan A; Heravi-Moussavi A; Salamanca C; Maines-Bandiera S; Huntsman DG; Morin GB
    J Pathol; 2013 Feb; 229(3):400-9. PubMed ID: 23132766
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Ricarte-Filho JC; Casado-Medrano V; Reichenberger E; Spangler Z; Scheerer M; Isaza A; Baran J; Patel T; MacFarland SP; Brodeur GM; Stewart DR; Baloch Z; Bauer AJ; Wasserman JD; Franco AT
    Front Endocrinol (Lausanne); 2023; 14():1083382. PubMed ID: 36896180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences.
    Pugh TJ; Yu W; Yang J; Field AL; Ambrogio L; Carter SL; Cibulskis K; Giannikopoulos P; Kiezun A; Kim J; McKenna A; Nickerson E; Getz G; Hoffher S; Messinger YH; Dehner LP; Roberts CW; Rodriguez-Galindo C; Williams GM; Rossi CT; Meyerson M; Hill DA
    Oncogene; 2014 Nov; 33(45):5295-302. PubMed ID: 24909177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis.
    Chen J; Wang Y; McMonechy MK; Anglesio MS; Yang W; Senz J; Maines-Bandiera S; Rosner J; Trigo-Gonzalez G; Grace Cheng SW; Kim J; Matzuk MM; Morin GB; Huntsman DG
    J Pathol; 2015 Oct; 237(2):215-25. PubMed ID: 26033159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
    Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
    Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
    Caruso S; Calderaro J; Letouzé E; Nault JC; Couchy G; Boulai A; Luciani A; Zafrani ES; Bioulac-Sage P; Seror O; Imbeaud S; Zucman-Rossi J
    J Hepatol; 2017 Apr; 66(4):734-742. PubMed ID: 28012864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the phenotype of mutations in DICER1: mosaic missense mutations in the RNase IIIb domain of DICER1 cause GLOW syndrome.
    Klein S; Lee H; Ghahremani S; Kempert P; Ischander M; Teitell MA; Nelson SF; Martinez-Agosto JA
    J Med Genet; 2014 May; 51(5):294-302. PubMed ID: 24676357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis.
    Vedanayagam J; Chatila WK; Aksoy BA; Majumdar S; Skanderup AJ; Demir E; Schultz N; Sander C; Lai EC
    Nat Commun; 2019 Aug; 10(1):3682. PubMed ID: 31417090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline and somatic DICER1 mutations in a pituitary blastoma causing infantile-onset Cushing's disease.
    Sahakitrungruang T; Srichomthong C; Pornkunwilai S; Amornfa J; Shuangshoti S; Kulawonganunchai S; Suphapeetiporn K; Shotelersuk V
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1487-92. PubMed ID: 24823459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRAME protein expression in DICER1-related tumours.
    Thorner PS; Chong AS; Nadaf J; Benlimame N; Marrano P; Chami R; Fu L; Foulkes WD
    J Pathol Clin Res; 2022 May; 8(3):294-304. PubMed ID: 35297207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagic degradation of SQSTM1 inhibits ovarian cancer motility by decreasing DICER1 and AGO2 to induce MIRLET7A-3P.
    Liao CC; Ho MY; Liang SM; Liang CM
    Autophagy; 2018; 14(12):2065-2082. PubMed ID: 30081720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pan-cancer atlas of somatic mutations in miRNA biogenesis genes.
    Galka-Marciniak P; Urbanek-Trzeciak MO; Nawrocka PM; Kozlowski P
    Nucleic Acids Res; 2021 Jan; 49(2):601-620. PubMed ID: 33406242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations.
    Koelsche C; Mynarek M; Schrimpf D; Bertero L; Serrano J; Sahm F; Reuss DE; Hou Y; Baumhoer D; Vokuhl C; Flucke U; Petersen I; Brück W; Rutkowski S; Zambrano SC; Garcia Leon JL; Diaz Coronado RY; Gessler M; Tirado OM; Mora J; Alonso J; Garcia Del Muro X; Esteller M; Sturm D; Ecker J; Milde T; Pfister SM; Korshunov A; Snuderl M; Mechtersheimer G; Schüller U; Jones DTW; von Deimling A
    Acta Neuropathol; 2018 Aug; 136(2):327-337. PubMed ID: 29881993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleuropulmonary Blastoma with Hotspot Mutations in RNase IIIb Domain of DICER 1: Clinicopathologic Study of 10 Cases in a Single-Institute Experience.
    Lee M; Kim TI; Jang SJ; Cho KJ; Lee SM; Kim HR; Song JS
    Pathobiology; 2021; 88(3):251-260. PubMed ID: 33567437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominant
    Lee YA; Im SW; Jung KC; Chung EJ; Shin CH; Kim JI; Park YJ
    Thyroid; 2020 Aug; 30(8):1120-1131. PubMed ID: 32228164
    [No Abstract]   [Full Text] [Related]  

  • 18. Anaplastic sarcomas of the kidney are characterized by DICER1 mutations.
    Wu MK; Vujanic GM; Fahiminiya S; Watanabe N; Thorner PS; O'Sullivan MJ; Fabian MR; Foulkes WD
    Mod Pathol; 2018 Jan; 31(1):169-178. PubMed ID: 28862265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.
    Durieux E; Descotes F; Mauduit C; Decaussin M; Guyetant S; Devouassoux-Shisheboran M
    Virchows Arch; 2016 May; 468(5):631-6. PubMed ID: 26983701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors.
    Rio Frio T; Bahubeshi A; Kanellopoulou C; Hamel N; Niedziela M; Sabbaghian N; Pouchet C; Gilbert L; O'Brien PK; Serfas K; Broderick P; Houlston RS; Lesueur F; Bonora E; Muljo S; Schimke RN; Bouron-Dal Soglio D; Arseneau J; Schultz KA; Priest JR; Nguyen VH; Harach HR; Livingston DM; Foulkes WD; Tischkowitz M
    JAMA; 2011 Jan; 305(1):68-77. PubMed ID: 21205968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.